Mainz Biomed (MYNZ) Accumulated Expenses (2021 - 2024)
Historic Accumulated Expenses for Mainz Biomed (MYNZ) over the last 4 years, with Q4 2024 value amounting to $822917.0.
- Mainz Biomed's Accumulated Expenses rose 1347.32% to $822917.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $822917.0, marking a year-over-year increase of 1347.32%. This contributed to the annual value of $822917.0 for FY2024, which is 1347.32% up from last year.
- Mainz Biomed's Accumulated Expenses amounted to $822917.0 in Q4 2024, which was up 1347.32% from $725208.0 recorded in Q4 2023.
- Mainz Biomed's 5-year Accumulated Expenses high stood at $1.0 million for Q4 2022, and its period low was $44447.0 during Q2 2022.
- Over the past 4 years, Mainz Biomed's median Accumulated Expenses value was $725208.0 (recorded in 2023), while the average stood at $572762.8.
- Its Accumulated Expenses has fluctuated over the past 5 years, first skyrocketed by 34393.99% in 2022, then tumbled by 3010.26% in 2023.
- Quarter analysis of 4 years shows Mainz Biomed's Accumulated Expenses stood at $233710.0 in 2021, then skyrocketed by 343.94% to $1.0 million in 2022, then tumbled by 30.1% to $725208.0 in 2023, then rose by 13.47% to $822917.0 in 2024.
- Its last three reported values are $822917.0 in Q4 2024, $725208.0 for Q4 2023, and $1.0 million during Q4 2022.